Constipation Treatment Market

Constipation Treatment Market (Therapeutic Option - Laxatives (Bulk Forming Agents, Osmotic Laxatives, and Stimulant Laxatives), Chloride Channel Activators, Peripherally Acting Mu Opioid Receptor Antagonists, GC-C Agonists, and 5-HT4 Receptor Agonists; Disease Type - Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation, and Opioid Induced Constipation; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL16442
  • Published On : Sep 2017
  • No. of Pages : 218
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Constipation Treatment Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
     4.5. Constipation Treatment Market Analysis and Forecast, 2017 – 2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s five forces analysis
     4.7. Global Prevalence of Chronic Constipation
     4.8. Global Prevalence if Irritable Bowel Syndrome
     4.9. Pipeline Analysis
     4.10. Value Chain Analysis
     4.11. Market Outlook

5. Global Constipation Treatment Market Analysis and Forecasts, By Therapeutic Option
     5.1. Introduction & Definition
     5.2. Key Findings
     5.3. Key Trends
     5.4. Market Size (US$ Mn) Forecast, By Therapeutic Option
            5.4.1. Laxatives
                       5.4.1.1. Bulk forming agents
                       5.4.1.2. Osmotic laxatives
                       5.4.1.3. Stimulant laxatives
                       5.4.1.4. Others
            5.4.2. Chloride channel activators
            5.4.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            5.4.4. GC-C Agonists
            5.4.5. 5-HT4 Receptor Agonists
     5.5. New Chronic Constipation Therapies Market Revenue (US$) Forecast, 2017-2025
     5.6. Market Attractiveness, By Therapeutic Option

6. Global Constipation Treatment Market Analysis and Forecasts, By Disease Type
     6.1. Introduction & Definition
     6.2. Key Findings 
     6.3. Key Trends
     6.4. Market Size (US$ Mn) Forecast, By Disease Type
            6.4.1. Chronic idiopathic constipation (CIC)
            6.4.2. Irritable bowel syndrome with constipation (IBS-C)
            6.4.3. Opioid-induced constipation (OIC)
     6.5. Market Attractiveness, By Disease Type

7. Global Constipation Treatment Market Analysis and Forecasts, By Distribution Channel
     7.1. Introduction & Definition
     7.2. Key Findings 
     7.3. Key Trends
     7.4. Market Size (US$ Mn) Forecast, By Distribution Chanel
            7.4.1. Hospital Pharmacies
            7.4.2. Retail Pharmacies
            7.4.3. Online Pharmacies
     7.5. Market Attractiveness, By Distribution Channel

8. Global Constipation Treatment Market Analysis and Forecasts, By Region
     8.1. Introduction & Definition
     8.2. Key Findings 
     8.3. Key Trends
     8.4. Market Size (US$ Mn) Forecast, By Region
            8.4.1. North America
            8.4.2. Europe
            8.4.3. Asia Pacific
            8.4.4. Latin America
            8.4.5. Middle East and Africa
            8.4.6. Commonwealth of Independent States
     8.5. Market Attractiveness, By Region

9. North America Constipation Treatment Market Analysis and Forecast
     9.1. Introduction
     9.2. Key Findings 
     9.3. Key Trends
     9.4. Market Size (US$ Mn) Forecast, By Therapeutic Option
            9.4.1. Laxatives
                       9.4.1.1. Bulk forming agents
                       9.4.1.2. Osmotic laxatives
                       9.4.1.3. Stimulant laxatives
                       9.4.1.4. Others
            9.4.2. Chloride channel activators
            9.4.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            9.4.4. GC-C Agonists
     9.5. Market Size (US$ Mn) Forecast, By Disease Type
            9.5.1. Chronic idiopathic constipation (CIC)
            9.5.2. Irritable bowel syndrome with constipation (IBS-C)
            9.5.3. Opioid-induced constipation (OIC)
     9.6. Market Size (US$ Mn) Forecast, By Distribution Chanel
            9.6.1. Hospital Pharmacies
            9.6.2. Retail Pharmacies
            9.6.3. Online Pharmacies
     9.7. Market Size by Value (US$ Mn) Forecast, By Country
            9.7.1. The U.S.
            9.7.2. Canada
     9.8. Market Attractiveness Analysis 
            9.8.1. By Therapeutic Option
            9.8.2. By Disease Type
            9.8.3. By Distribution Channel
            9.8.4. By Country

10.  Europe Constipation Treatment Market Analysis and Forecast
     10.1. Introduction
     10.2. Key Findings 
     10.3. Key Trends
     10.4. Market Size (US$ Mn) Forecast, By Therapeutic Option
            10.4.1. Laxatives
                       10.4.1.1. Bulk forming agents
                       10.4.1.2. Osmotic laxatives
                       10.4.1.3. Stimulant laxatives
                       10.4.1.4. Others
            10.4.2. Chloride channel activators
            10.4.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            10.4.4. GC-C Agonists
            10.4.5. 5-HT4 Receptor Agonists
     10.5. Market Size (US$ Mn) Forecast, By Disease Type
            10.5.1. Chronic idiopathic constipation (CIC)
            10.5.2. Irritable bowel syndrome with constipation (IBS-C)
            10.5.3. Opioid-induced constipation (OIC)
     10.6. Market Size (US$ Mn) Forecast, By Distribution Chanel
            10.6.1. Hospital Pharmacies
            10.6.2. Retail Pharmacies
            10.6.3. Online Pharmacies
     10.7. Market Size by Value (US$ Mn) Forecast, By Country
            10.7.1. Germany
            10.7.2. France
            10.7.3. U.K.
            10.7.4. Spain
            10.7.5. Italy
            10.7.6. Rest of Europe
     10.8. Market Attractiveness Analysis 
            10.8.1. By Therapeutic Option
            10.8.2. By Disease Type
            10.8.3. By Distribution Channel
            10.8.4. By Country

11.  Asia Pacific Constipation Treatment Market Analysis and Forecast
     11.1. Introduction
     11.2. Key Findings 
     11.3. Regulatory Scenario 
     11.4. Key Trends
     11.5. Market Size (US$ Mn) Forecast, By Therapeutic Option
            11.5.1. Laxatives
                       11.5.1.1. Bulk forming agents
                       11.5.1.2. Osmotic laxatives
                       11.5.1.3. Stimulant laxatives
                       11.5.1.4. Others
            11.5.2. Chloride channel activators
            11.5.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            11.5.4. GC-C Agonists
            11.5.5. 5-HT4 Receptor Agonists
     11.6. Market Size (US$ Mn) Forecast, By Disease Type
            11.6.1. Chronic idiopathic constipation (CIC)
            11.6.2. Irritable bowel syndrome with constipation (IBS-C)
            11.6.3. Opioid-induced constipation (OIC)
     11.7. Market Size (US$ Mn) Forecast, By Distribution Chanel
            11.7.1. Hospital Pharmacies
            11.7.2. Retail Pharmacies
            11.7.3. Online Pharmacies
     11.8. Market Size by Value (US$ Mn) Forecast, By Country
            11.8.1. Philippines
            11.8.2. Thailand
            11.8.3. Indonesia
            11.8.4. South Korea
            11.8.5. Singapore
            11.8.6. Malaysia
            11.8.7. Rest of Asia Pacific
     11.9. Market Attractiveness Analysis 
            11.9.1. By Therapeutic Option
            11.9.2. By Disease Type
            11.9.3. By Distribution Channel
            11.9.4. By Country

12.  Latin America Constipation Treatment Market Analysis and Forecast
     12.1. Introduction
     12.2. Key Findings 
     12.3. Regulatory Scenario 
     12.4. Key Trends
     12.5. Market Size (US$ Mn) Forecast, By Therapeutic Option
            12.5.1. Laxatives
                       12.5.1.1. Bulk forming agents
                       12.5.1.2. Osmotic laxatives
                       12.5.1.3. Stimulant laxatives
                       12.5.1.4. Others
            12.5.2. Chloride channel activators
            12.5.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            12.5.4. GC-C Agonists
            12.5.5. 5-HT4 Receptor Agonists
     12.6. Market Size (US$ Mn) Forecast, By Disease Type
            12.6.1. Chronic idiopathic constipation (CIC)
            12.6.2. Irritable bowel syndrome with constipation (IBS-C)
            12.6.3. Opioid-induced constipation (OIC)
     12.7. Market Size (US$ Mn) Forecast, By Distribution Chanel
            12.7.1. Hospital Pharmacies
            12.7.2. Retail Pharmacies
            12.7.3. Online Pharmacies
     12.8. Market Size by Value (US$ Mn) Forecast, By Country
            12.8.1. Brazil
            12.8.2. Mexico
            12.8.3. Argentina
            12.8.4. Ecuador
            12.8.5. Peru
            12.8.6. Rest of Latin America
     12.9. Market Attractiveness Analysis 
            12.9.1. By Therapeutic Option
            12.9.2. By Disease Type
            12.9.3. By Distribution Channel
            12.9.4. By Country

13.  Middle East and Africa Constipation Treatment Market Analysis and Forecast
     13.1. Introduction
     13.2. Key Findings 
     13.3. Regulatory Scenario      
     13.4. Key Trends
     13.5. Market Size (US$ Mn) Forecast, By Therapeutic Option
            13.5.1. Laxatives
                       13.5.1.1. Bulk forming agents
                       13.5.1.2. Osmotic laxatives
                       13.5.1.3. Stimulant laxatives
                       13.5.1.4. Others
            13.5.2. Chloride channel activators
            13.5.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            13.5.4. GC-C Agonists
            13.5.5. 5-HT4 Receptor Agonists
     13.6. Market Size (US$ Mn) Forecast, By Disease Type
            13.6.1. Chronic idiopathic constipation (CIC)
            13.6.2. Irritable bowel syndrome with constipation (IBS-C)
            13.6.3. Opioid-induced constipation (OIC)
     13.7. Market Size (US$ Mn) Forecast, By Distribution Chanel
            13.7.1. Hospital Pharmacies
            13.7.2. Retail Pharmacies
            13.7.3. Online Pharmacies
     13.8. Market Size by Value (US$ Mn) Forecast, By Country
            13.8.1. Saudi Arabia
            13.8.2. South Africa
            13.8.3. Rest of Middle East and Africa
     13.9. Market Attractiveness Analysis 
            13.9.1. By Therapeutic Option
            13.9.2. By Disease Type
            13.9.3. By Distribution Channel
            13.9.4. By Country

14.  Commonwealth of Independent States Constipation Treatment Market Analysis and Forecast
     14.1. Introduction
     14.2. Key Findings 
     14.3. Market Size (US$ Mn) Forecast, By Therapeutic Option
            14.3.1. Laxatives
                       14.3.1.1. Bulk forming agents
                       14.3.1.2. Osmotic laxatives
                       14.3.1.3. Stimulant laxatives
                       14.3.1.4. Others
            14.3.2. Chloride channel activators
            14.3.3. Peripherally Acting Mu-Opioid Receptor Antagonists
            14.3.4. GC-C Agonists
            14.3.5. 5-HT4 Receptor Agonists
     14.4. Market Size (US$ Mn) Forecast, By Disease Type
            14.4.1. Chronic idiopathic constipation (CIC)
            14.4.2. Irritable bowel syndrome with constipation (IBS-C)
            14.4.3. Opioid-induced constipation (OIC)
     14.5. Market Size (US$ Mn) Forecast, By Distribution Chanel
            14.5.1. Hospital Pharmacies
            14.5.2. Retail Pharmacies
            14.5.3. Online Pharmacies
     14.6. Market Size by Value (US$ Mn) Forecast, By Country
            14.6.1. Russian Federation
            14.6.2. Ukraine
            14.6.3. Kazakhstan
     14.7. Market Attractiveness Analysis 
            14.7.1. By Therapeutic Option
            14.7.2. By Disease Type
            14.7.3. By Distribution Channel
            14.7.4. By Country

15.  Competition Landscape
     15.1. Market Player – Competition Matrix (By Tier and Size of companies)
     15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            15.2.1. Takeda Pharmaceutical Company Ltd
                       15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.1.2. Product Portfolio
                       15.2.1.3. SWOT Analysis
                       15.2.1.4. Financial Overview
                       15.2.1.5. Strategic Overview
            15.2.2. Synergy Pharmaceuticals, Inc.
                       15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.2.2. Product Portfolio
                       15.2.2.3. SWOT Analysis
                       15.2.2.4. Financial Overview
                       15.2.2.5. Strategic Overview
            15.2.3. Sucampo Pharmaceuticals, Inc.
                       15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.3.2. Product Portfolio
                       15.2.3.3. SWOT Analysis
                       15.2.3.4. Financial Overview
                       15.2.3.5. Strategic Overview
            15.2.4. Ironwood Pharmaceuticals, Inc.
                       15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.4.2. Product Portfolio
                       15.2.4.3. SWOT Analysis
                       15.2.4.4. Financial Overview
                       15.2.4.5. Strategic Overview
            15.2.5. Valeant Pharmaceuticals International, Inc.
                       15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.5.2. Product Portfolio
                       15.2.5.3. SWOT Analysis
                       15.2.5.4. Financial Overview
                       15.2.5.5. Strategic Overview
            15.2.6. Abbott Laboratories
                       15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.6.2. Product Portfolio
                       15.2.6.3. SWOT Analysis
                       15.2.6.4. Financial Overview
                       15.2.6.5. Strategic Overview
            15.2.7. AstraZeneca
                       15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.7.2. Product Portfolio
                       15.2.7.3. SWOT Analysis
                       15.2.7.4. Financial Overview
                       15.2.7.5. Strategic Overview
            15.2.8. Cosmo Pharmaceuticals NV
                       15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.8.2. Product Portfolio
                       15.2.8.3. SWOT Analysis
                       15.2.8.4. Financial Overview
                       15.2.8.5. Strategic Overview
            15.2.9. Sanofi
                       15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.9.2. Product Portfolio
                       15.2.9.3. SWOT Analysis
                       15.2.9.4. Financial Overview
                       15.2.9.5. Strategic Overview
            15.2.10. Daewoong Pharmaceuticals Co. Ltd.
                       15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.10.2. Product Portfolio
                       15.2.10.3. SWOT Analysis
                       15.2.10.4. Financial Overview
                       15.2.10.5. Strategic Overview
            15.2.11. Bayer AG
                       15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.11.2. Product Portfolio
                       15.2.11.3. SWOT Analysis
                       15.2.11.4. Financial Overview
                       15.2.11.5. Strategic Overview
            15.2.12. Prestige Brands Holdings, Inc.
                       15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.12.2. Product Portfolio
                       15.2.12.3. SWOT Analysis
                       15.2.12.4. Financial Overview
                       15.2.12.5. Strategic Overview
            15.2.13. Janssen Pharmaceutical Company
                       15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.13.2. Product Portfolio
                       15.2.13.3. SWOT Analysis
                       15.2.13.4. Financial Overview
                       15.2.13.5. Strategic Overview
            15.2.14. Shionogi & Co., Ltd.
                       15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.14.2. Product Portfolio
                       15.2.14.3. SWOT Analysis
                       15.2.14.4. Financial Overview
                       15.2.14.5. Strategic Overview
            15.2.15. Albireo Pharma, Inc.
                       15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.15.2. Product Portfolio
                       15.2.15.3. SWOT Analysis
                       15.2.15.4. Financial Overview
                       15.2.15.5. Strategic Overview
            15.2.16. Renexxion, LLC
                       15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
                       15.2.16.2. Product Portfolio
                       15.2.16.3. SWOT Analysis
                       15.2.16.4. Strategic Overview

16. Key Takeaways

List of Tables

Table 01: Pipeline Analysis, By Phase 3 Drugs
Table 02 : Pipeline Analysis, By Phase 2 (1/2)
Table 03: Pipeline Analysis, By phase 2 (2/2)
Table 04: Global Constipation Treatment Market Size (US$ Mn) Forecast, by Therapeutic Option, 2015–2025
Table 05: Global Constipation Treatment Market Size (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 06: Global Constipation Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 07: Global Constipation Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 08: Global Constipation Treatment Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option,2015–2025
Table 10: North America Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 11: North America Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 12: North America Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,2015–2025
Table 13: North America Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2015–2025
Table 14: Europe Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option, 2015–2025
Table 15: Europe Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 16: Europe Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 17: Europe Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Europe Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 19: Asia Pacific Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option, 2015–2025
Table 20: Asia Pacific Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 21: Asia Pacific Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 22: Asia Pacific Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 23: Asia Pacific Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 24: Latin America Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option,2015–2025
Table 25: Latin America Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 26: Latin America Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 27: Latin America Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,2015–2025
Table 28: Latin America Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 29: Middle East & Africa Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option, 2015–2025
Table 30: Middle East & Africa Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 31: Middle East & Africa Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 32: Middle East & Africa Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 33: Middle East & Africa Constipation Treatment Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 34: CIS Constipation Treatment Market Value (US$ Mn) Forecast, by Therapeutic Option, 2015–2025
Table 35: CIS Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2015–2025
Table 36: CIS Constipation Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 37: CIS Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 38: CIS Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

List of Figures

Figure 01: Global Constipation Treatment Market, by Therapeutic Option, Market Size (US$ Mn), 2016 (A)
Figure 02: Global Constipation Treatment Market Revenue (%), by Disease Type, 2016 (A)
Figure 03: Global Constipation Treatment Market Size (US$ Mn) Forecast, 2015–2025
Figure 04: Global Prevalence of Constipation
Figure 05: Global Prevalence of Irritable Bowel Syndrome
Figure 06: Market Value Share, by Therapeutic Option (2016)
Figure 07: Market Value Share, by Disease Type (2016)
Figure 08: Market Value Share, by Distribution Channel (2016)
Figure 09: Global Constipation Treatment Market Value Share, by Therapeutic Option, 2016 and 2025
Figure 10: Global Constipation Treatment Market Attractiveness, by Therapeutic Option, 2017–2025
Figure 11: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laxatives, 2015–2025
Figure 12: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chloride Channel Activator, 2015–2025
Figure 13: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PAMORA 2015–2025
Figure 14: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by GC-C Agonists, 2015–2025
Figure 15: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by 5-HT4 Receptor Agonists 2015–2025
Figure 16: Global Constipation Treatment Market Value Share, by Disease Type, 2016 and 2025
Figure 17: Global Constipation Treatment Market Attractiveness, by Disease Type, 2017–2025
Figure 18: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CIC, 2015–2025
Figure 19: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by IBS-C, 2015–2025
Figure 20: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by OIC, 2015–2025
Figure 21: Global Constipation Treatment Market Value Share, by Distribution Channel, 2016 and 2025
Figure 22: Global Constipation Treatment Market Attractiveness, by Distribution Channel, 2017–2025
Figure 23: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
Figure 24: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015–2025
Figure 25: Global Constipation Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2015–2025
Figure 26: Global Constipation Treatment Market Value Share, by Region, 2017 and 2025 
Figure 27: Global Constipation Treatment Market Attractiveness, by Region, 2017–2025
Figure 28: North America Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 29: North America Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 30: North America Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 31: North America Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 32: North America Constipation Treatment Market Value Share Analysis, by Country, 2016 and 2025
Figure 33: North America Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 34: North America Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 35: North America Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 36: North America Constipation Treatment Market Attractiveness Analysis, by Country
Figure 37: Europe Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 38: Europe Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 39: Europe Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 40: Europe Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 41: Europe Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 42: Europe Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 43: Europe Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 44: Europe Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 45: Europe Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region
Figure 46: Asia Pacific Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 47: Asia Pacific Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 48: Asia Pacific Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 49: Asia Pacific Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 50: Asia Pacific Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 51: Asia Pacific Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 52: Asia Pacific Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 53: Asia Pacific Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 54: Asia Pacific Constipation Treatment Market Attractiveness Analysis, by Country
Figure 55: Latin America Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 56: Latin America Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 57: Latin America Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 58: Latin America Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 59: Latin America Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 60: Latin America Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 61: Latin America Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 62: Latin America Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 63: Latin America Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region
Figure 64: Middle East & Africa Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 65: Middle East & Africa Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 66: Middle East & Africa Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 67: Middle East & Africa Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 68: Middle East & Africa Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 69: Middle East & Africa Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 70: Middle East & Africa Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 71: Middle East & Africa Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 72: Middle East & Africa Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region
Figure 73: CIS Constipation Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 74: CIS Constipation Treatment Market Value Share Analysis, by Therapeutic Option, 2016 and 2025
Figure 75: CIS Constipation Treatment Market Value Share Analysis, by Disease Type, 2016 and 2025
Figure 76: CIS Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 77: CIS Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 78: CIS Constipation Treatment Market Attractiveness Analysis, by Therapeutic Option
Figure 79: CIS Constipation Treatment Market Attractiveness Analysis, by Disease Type
Figure 80: CIS Constipation Treatment Market Attractiveness Analysis, by Distribution Channel 
Figure 81: CIC Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region